Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED)

NCT00551330 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections
Acquired Immunodeficiency Syndrome

Interventions

DRUG: Vicriviroc
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC